Kerrisdale Advisers’s ACM Research ACMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.8M Sell
223,755
-39,727
-15% -$2.11M 3.35% 6
2025
Q4
$10.4M Buy
263,482
+86,901
+49% +$3.24M 4.9% 5
2025
Q3
$6.91M Sell
176,581
-109,916
-38% -$3.26M 3.58% 9
2025
Q2
$7.42M Buy
286,497
+72,100
+34% +$1.62M 3.87% 8
2025
Q1
$5M Sell
214,397
-1,733,606
-89% -$39.6M 2.09% 14
2024
Q4
$29.4M Buy
1,948,003
+1,648,685
+551% +$29.8M 9.94% 1
2024
Q3
$6.08M Buy
+299,318
New +$5.74M 2.07% 17

Other funds holding ACMR

Kerrisdale Advisers's ACMR Position: Q1 2026 in Review

Kerrisdale Advisers reduced its ACM Research (ACMR) stake by 15% in Q1 2026, selling an estimated $2.11M and leaving 223,755 shares worth $8.8M. The position accounts for 3.35% of the portfolio, ranked #6.

Kerrisdale Advisers first reported a position in ACMR in Q3 2024 and has held it in 7 quarters since. The position peaked at $29.4M in Q4 2024. 300 funds tracked by Wall St. Rank hold ACMR as of Q1 2026.

  • Kerrisdale Advisers held 223,755 shares of ACM Research worth $8.8M as of Q1 2026.
  • Kerrisdale Advisers sold 39,727 ACM Research shares in Q1 2026, an estimated $2.11M.
  • ACM Research made up 3.35% of Kerrisdale Advisers's portfolio in Q1 2026, its #6 holding.
  • Kerrisdale Advisers first reported a position in ACM Research in Q3 2024 and has held it in 7 quarters since.
  • Kerrisdale Advisers's ACM Research position peaked at $29.4M in Q4 2024.
  • 300 funds tracked by Wall St. Rank held ACM Research as of Q1 2026.

Based on Kerrisdale Advisers's 13F filing for Q1 2026, filed 15 May 2026.